AusperBio

Healthcare & Life Sciences

Recent Finacing

Recent Raise

AusperBio is a biotechnology company developing targeted oligonucleotide therapies for chronic hepatitis B and other chronic diseases.

Total Funding

Headquarters

Founded

Website

Focus Areas

Biotechnology

Oligonucleotide Therapies

Chronic Hepatitis B

Med-Oligo™ Platform

Therapeutic Pipeline

Manufacturing Capabilities

Investors